Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open, prospective, single arm study investigating efficacy and safety of human hepatitis B immunoglobulin Zutectra in liver transplanted patients - the ZEUS Study

Next Previous
X
Search
Trial Profile

An open, prospective, single arm study investigating efficacy and safety of human hepatitis B immunoglobulin Zutectra in liver transplanted patients - the ZEUS Study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 31 Jan 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis B immune globulin (Primary)
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Acronyms ZEUS
  • Sponsors Biotest AG

    • Most Recent Events

    • 26 Jan 2019 This trial has been completed in the United Kingdom according to the European Clinical Trials Database record.
    • 23 Apr 2015 According to a Biotest media release, the dossier for "Zutectra-early-use" which will allow earliest conversion to subcutaneous administration of Zutectra at the earliest one week after liver transplantation has been submitted to the European Medicines Agency (EMA) for EU-Approval. The approval process is expected to be finalized in the fourth quarter of 2015.
    • 23 Apr 2015 According to a Biotest media release, the results from this trial were presented at the 50th International Liver Congress 2015.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top